Morgan Stanley’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.35M | Buy |
3,753,613
+702,099
| +23% | +$814K | ﹤0.01% | 4165 |
|
|
2025
Q1 | $4.12M | Buy |
3,051,514
+2,269,510
| +290% | +$3.06M | ﹤0.01% | 4091 |
|
|
2024
Q4 | $10.3M | Sell |
782,004
-35,119
| -4% | -$463K | ﹤0.01% | 3384 |
|
|
2024
Q3 | $9.16M | Buy |
817,123
+143,276
| +21% | +$1.61M | ﹤0.01% | 3497 |
|
|
2024
Q2 | $7.24M | Buy |
673,847
+289,745
| +75% | +$3.11M | ﹤0.01% | 3584 |
|
|
2024
Q1 | $5.72M | Sell |
384,102
-425,944
| -53% | -$6.35M | ﹤0.01% | 3809 |
|
|
2023
Q4 | $14.7M | Buy |
810,046
+716,043
| +762% | +$13M | ﹤0.01% | 3611 |
|
|
2023
Q3 | $1.63M | Buy |
94,003
+6,280
| +7% | +$109K | ﹤0.01% | 4515 |
|
|
2023
Q2 | $1.59M | Sell |
87,723
-197,741
| -69% | -$3.58M | ﹤0.01% | 4567 |
|
|
2023
Q1 | $7.59M | Buy |
285,464
+171,484
| +150% | +$4.56M | ﹤0.01% | 3398 |
|
|
2022
Q4 | $2.2M | Sell |
113,980
-99,713
| -47% | -$1.93M | ﹤0.01% | 4396 |
|
|
2022
Q3 | $4.46M | Sell |
213,693
-142,346
| -40% | -$2.97M | ﹤0.01% | 3790 |
|
|
2022
Q2 | $2.85M | Buy |
356,039
+33,275
| +10% | +$266K | ﹤0.01% | 4253 |
|
|
2022
Q1 | $2.26M | Sell |
322,764
-20,356
| -6% | -$143K | ﹤0.01% | 4423 |
|
|
2021
Q4 | $4.63M | Buy |
343,120
+191,875
| +127% | +$2.59M | ﹤0.01% | 3800 |
|
|
2021
Q3 | $2.55M | Buy |
151,245
+117,550
| +349% | +$1.99M | ﹤0.01% | 4374 |
|
|
2021
Q2 | $982K | Buy |
33,695
+29,372
| +679% | +$856K | ﹤0.01% | 5090 |
|
|
2021
Q1 | $170K | Sell |
4,323
-5,284
| -55% | -$208K | ﹤0.01% | 5756 |
|
|
2020
Q4 | $218K | Sell |
9,607
-6,649
| -41% | -$151K | ﹤0.01% | 5546 |
|
|
2020
Q3 | $368K | Buy |
16,256
+14,556
| +856% | +$330K | ﹤0.01% | 4793 |
|
|
2020
Q2 | $55K | Buy |
+1,700
| New | +$55K | ﹤0.01% | 5647 |
|